LETAIRIS vs UPTRAVI
Independent side-by-side comparison.
Possible drug interaction. LETAIRIS and UPTRAVI are different prescription medicines. Combining or switching between them can cause interactions — talk to a pharmacist or prescriber before making changes. This page is not medical advice.
Rating
70/100
New
Pharmacy pays
~$255.61 /30
—
Type
RX
RX
Active ingredient
AMBRISENTAN
SELEXIPAG
Manufacturer
Dosage forms
Tablet
Injectable, Tablet
Drug class
Endothelin Receptor Antagonist
—
Boxed warning
None
Treats
Pulmonary Hypertension
Pulmonary Hypertension
Frequently asked questions
What is the difference between Letairis and Uptravi?
Letairis contains Ambrisentan, while Uptravi contains Selexipag — they have different active ingredients.
Ratings are based on FDA regulatory (recall-safety) data. This comparison is for general reference only — not medical advice. Always consult a licensed professional before choosing or switching a medication.